newsfilter
← Latest News
GlobeNewswire·

Applied Therapeutics Files Form 12b-25 with the Securities and Exchange Commission

NEW YORK, March 31, 2025 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (NASDAQ:APLT) (the "Company"), a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated